- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-3111
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Renin–Angiotensin–Aldosterone Inhibitors and COVID-19 Infection ; day:18 ; month:6 ; year:2022 ; pages:1-9
Current hypertension reports ; (18.6.2022), 1-9
- Creator
-
Tsampasian, Vasiliki
Corballis, Natasha
Vassiliou, Vassilios S.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11906-022-01207-3
- URN
-
urn:nbn:de:101:1-2022081220042022921517
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tsampasian, Vasiliki
- Corballis, Natasha
- Vassiliou, Vassilios S.
- SpringerLink (Online service)
Other Objects (12)
The renin angiotensin aldosterone system
Symposium Renin-Angiotensin-Aldosterone System and Hypertension
Recommendations for the management of hyperkalemia in patients receiving renin–angiotensin–aldosterone system inhibitors
Impact of hyperkalaemia on renin–angiotensin–aldosterone (RAAS) inhibitor reduction or withdrawal following hospitalisation
Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19
Independent regulation of renin–angiotensin–aldosterone system in the kidney
Renin angiotensin aldosterone system blockade in practice: A Clinical Perspective
Local Angiotensin-Converting Enzyme 2 Gene Expression in Kidney Allografts Is Not Affected by Renin-Angiotensin-Aldosterone Inhibitors
Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors Secondary to Hyperkalemia Translates into Higher Cardiorenal Outcomes
The renin–angiotensin–aldosterone-system in sepsis and its clinical modulation with exogenous angiotensin II
Cross-talk between exercises and renin-angiotensin-aldosterone-system blockade in hypertension
Role of Renin-Angiotensin-Aldosterone System (RAAS) inhibition in the renal continuum
The renin angiotensin aldosterone system
Symposium Renin-Angiotensin-Aldosterone System and Hypertension
Recommendations for the management of hyperkalemia in patients receiving renin–angiotensin–aldosterone system inhibitors
Impact of hyperkalaemia on renin–angiotensin–aldosterone (RAAS) inhibitor reduction or withdrawal following hospitalisation
Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19
Independent regulation of renin–angiotensin–aldosterone system in the kidney
Renin angiotensin aldosterone system blockade in practice: A Clinical Perspective
Local Angiotensin-Converting Enzyme 2 Gene Expression in Kidney Allografts Is Not Affected by Renin-Angiotensin-Aldosterone Inhibitors
Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors Secondary to Hyperkalemia Translates into Higher Cardiorenal Outcomes
The renin–angiotensin–aldosterone-system in sepsis and its clinical modulation with exogenous angiotensin II
Cross-talk between exercises and renin-angiotensin-aldosterone-system blockade in hypertension
Role of Renin-Angiotensin-Aldosterone System (RAAS) inhibition in the renal continuum
The renin angiotensin aldosterone system
Symposium Renin-Angiotensin-Aldosterone System and Hypertension
Recommendations for the management of hyperkalemia in patients receiving renin–angiotensin–aldosterone system inhibitors
Impact of hyperkalaemia on renin–angiotensin–aldosterone (RAAS) inhibitor reduction or withdrawal following hospitalisation
Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19
Independent regulation of renin–angiotensin–aldosterone system in the kidney
Renin angiotensin aldosterone system blockade in practice: A Clinical Perspective
Local Angiotensin-Converting Enzyme 2 Gene Expression in Kidney Allografts Is Not Affected by Renin-Angiotensin-Aldosterone Inhibitors
Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors Secondary to Hyperkalemia Translates into Higher Cardiorenal Outcomes
The renin–angiotensin–aldosterone-system in sepsis and its clinical modulation with exogenous angiotensin II
Cross-talk between exercises and renin-angiotensin-aldosterone-system blockade in hypertension